Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
After-Hours: 20:00
Enveric Biosciences Price to Book Value: 3.654 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.654 |
| May 02, 2024 | 3.451 |
| May 01, 2024 | 3.467 |
| April 30, 2024 | 3.505 |
| April 29, 2024 | 3.541 |
| April 26, 2024 | 3.337 |
| April 25, 2024 | 3.356 |
| April 24, 2024 | 3.482 |
| April 23, 2024 | 3.346 |
| April 22, 2024 | 3.210 |
| April 19, 2024 | 3.283 |
| April 18, 2024 | 3.497 |
| April 17, 2024 | 3.288 |
| April 16, 2024 | 3.397 |
| April 15, 2024 | 3.436 |
| April 12, 2024 | 3.766 |
| April 11, 2024 | 3.394 |
| April 10, 2024 | 3.461 |
| April 09, 2024 | 3.509 |
| April 08, 2024 | 3.430 |
| April 05, 2024 | 3.467 |
| April 04, 2024 | 3.546 |
| April 03, 2024 | 3.766 |
| April 02, 2024 | 4.250 |
| April 01, 2024 | 3.318 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.728 |
| March 27, 2024 | 3.803 |
| March 26, 2024 | 3.952 |
| March 25, 2024 | 3.915 |
| March 22, 2024 | 4.213 |
| March 21, 2024 | 4.362 |
| March 20, 2024 | 3.365 |
| March 19, 2024 | 3.422 |
| March 18, 2024 | 3.163 |
| March 15, 2024 | 3.106 |
| March 14, 2024 | 3.163 |
| March 13, 2024 | 3.336 |
| March 12, 2024 | 3.451 |
| March 11, 2024 | 3.642 |
| March 08, 2024 | 3.89 |
| March 07, 2024 | 4.194 |
| March 06, 2024 | 1.932 |
| March 05, 2024 | 1.974 |
| March 04, 2024 | 2.170 |
| March 01, 2024 | 2.324 |
| February 29, 2024 | 2.030 |
| February 28, 2024 | 1.164 |
| February 27, 2024 | 1.176 |
| February 26, 2024 | 1.192 |
| February 23, 2024 | 1.372 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.152
Minimum
Dec 28 2022
26.40
Maximum
Feb 11 2021
1.894
Average
0.8029
Median
Nov 25 2020
Price to Book Value Benchmarks
| Seelos Therapeutics Inc | -- |
| Societal CDMO Inc (DELISTED) | 1.982 |
| Cardiff Oncology Inc | 2.255 |
| BioVie Inc | 2.610 |
| Adial Pharmaceuticals Inc | 1.688 |
Price to Book Value Related Metrics
| PS Ratio | 0.0545 |
| Price | 0.98 |
| Earnings Yield | -828.6% |
| Market Cap | 7.148M |